← Eichor
Condition: Hemostatic Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hemostatic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

"Pseudo-scanner" MRI Sequences for the Detection of Bone Lesions in Multiple Myeloma
NA · 1 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT06988020Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders
Phase N/A · 1 location(s) · Nicoletta C Machin · NCT07083583Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
Phase 1 · 1 location(s) · The Third Affiliated Hospital of Southern Medical University · NCT06758713Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequenti
Phase 2 · 11 location(s) · SCRI Development Innovations, LLC · NCT06974786This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings
Phase N/A · 1 location(s) · Rigshospitalet, Denmark · NCT07160270Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients Wi
Phase 2 · 1 location(s) · Medical College of Wisconsin · NCT04240054A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Phase 2 · 38 location(s) · Janssen Research & Development, LLC · NCT06500884A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacyti
Phase 2 · 9 location(s) · Memorial Sloan Kettering Cancer Center · NCT07231952Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Mu
Phase 3 · 28 location(s) · Canadian Cancer Trials Group · NCT06182774A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma
EARLY_Phase 1 · 4 location(s) · Suzhou Immunofoco Biotechnology Co., Ltd · NCT07493135Precision Medicine Study
Phase N/A · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06338150Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Partici
Phase 3 · 212 location(s) · European Myeloma Network B.V. · NCT05243797Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level
Phase 3 · 5 location(s) · University of Leeds · NCT07649525Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematologi
Phase N/A · 5 location(s) · Medical University Innsbruck · NCT06821880Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia
Phase N/A · 1 location(s) · Imperial College London · NCT00230685In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07239323A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilz
Phase 1/Phase 2 · 84 location(s) · BeOne Medicines · NCT04973605A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in
Phase 1 · 2 location(s) · Mayo Clinic · NCT03017820Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed
Phase 2 · 1 location(s) · Naresh Bumma · NCT07657312Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
Phase 1 · 1 location(s) · Hackensack Meridian Health · NCT03909412Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies U
Phase N/A · 1 location(s) · Mayo Clinic · NCT06151730Comparison of Efficacy and Safety of Manual Syringing Versus Pneumatic Pressure Bag for Blood Transfusion in Patients Un
NA · 1 location(s) · Aswan University · NCT07466719BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma
Phase 1 · 2 location(s) · iCell Gene Therapeutics · NCT04162353Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT04888039Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
NA · 1 location(s) · University of Nebraska · NCT04898790Progression Assessment of PXE-associated Alterations
Phase N/A · 1 location(s) · University Hospital, Bonn · NCT07048106Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
Phase 1 · 1 location(s) · Christopher Strouse · NCT07581704At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms
Phase N/A · 1 location(s) · iOMEDICO AG · NCT06043011A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induc
Phase 1 · 20 location(s) · Bayer · NCT06854640
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.